论文部分内容阅读
本文观察口服心喘齐灵治疗52例冠心病心绞痛的临床疗效,治疗2mo后心绞痛症状疗效总有效率为83％,心电图改善总有效率为67％,对ST段压低及ST-T改变者效果较好。观察中发现本药能明显抑制血小板聚集,对血压、心率、心收缩功能无明显改变,进一步证明该药能降低心肌耗氧和增加冠状动脉流量。作者等认为心喘齐灵能改善冠心病心绞痛症状,副作用小,是一种新型有效的抗心绞痛药物。
This article observed 52 cases of oral angina Qi Ling clinical efficacy of angina pectoris, after 2mo treatment of angina pectoris the total effective rate was 83%, the total effective rate of ECG improvement was 67%, ST-segment depression and ST-T changes in effect better. Observation found that the drug can significantly inhibit platelet aggregation, blood pressure, heart rate, cardiac systolic function was no significant change, further evidence that the drug can reduce myocardial oxygen consumption and increase coronary flow. The authors believe that brave Qi Ling can improve coronary heart disease angina symptoms, side effects, is a new and effective anti-angina drugs.